$117.63 -1.24 (%) Celgene Corp - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Bluebird Rockets On Myeloma Drug; Celgene Gets Boost

    Investors Business Daily | Dec. 1, 2016 | 12:10PM EST
  2. Bluebird Bio, Celgene Multiple Myeloma Therapy Shines In 9-Patient Study

    Investors Business Daily | Nov. 30, 2016 | 18:58PM EST
  3. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  4. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  5. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
  6. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  7. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  8. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  9. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  10. When Is The PEG Ratio Superior to the P/E Ratio? Part 2

    TalkMarkets | Nov. 4, 2016 | 06:48AM EST
  11. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  12. Gilead Sciences, Inc.: Why You Should Go Long On Gilead Stock?

    TalkMarkets | Oct. 28, 2016 | 15:30PM EST
  13. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  14. 5 Stocks To Watch Before The Market Opens Tomorrow (October 27, 2016)

    TalkMarkets | Oct. 26, 2016 | 16:50PM EST
  15. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets | Oct. 18, 2016 | 10:16AM EST
  16. Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally

    TalkMarkets | Oct. 12, 2016 | 23:02PM EST
  17. Short Setups For This Choppy Market

    TalkMarkets | Sep. 28, 2016 | 15:29PM EST
  18. Biotech Stocks Pause At Resistance: IBB

    TalkMarkets | Sep. 26, 2016 | 23:20PM EST
  19. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 20:00PM EST
  20. Celgene Upgraded; Alibaba Price Target Bullish; Square, EA Targets Hiked

    Investors Business Daily | Aug. 4, 2016 | 08:28AM EST
  21. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?

    Investors Business Daily | Aug. 2, 2016 | 15:09PM EST
  22. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40

    Investors Business Daily | Aug. 1, 2016 | 17:08PM EST
  23. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily | Aug. 1, 2016 | 14:15PM EST
  24. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 11:20AM EST
  25. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  26. Stock Indexes Add Tiny Gains, But Biotech Celgene Rockets; Is It Time To Buy?

    Investors Business Daily | Jul. 28, 2016 | 15:40PM EST
  27. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 09:30AM EST
  28. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily | Jul. 27, 2016 | 16:45PM EST
  29. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily | Jul. 27, 2016 | 12:51PM EST
  30. Celgene Slides After Deciding Against Revlimid Label Expansion

    Investors Business Daily | Jul. 26, 2016 | 11:27AM EST
  31. Celgene Falls After Blockbuster Cancer Drug Revlimid Fails To Extend Survival

    Investors Business Daily | Jul. 25, 2016 | 17:08PM EST
  32. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles

    Investors Business Daily | Jul. 25, 2016 | 04:00AM EST
  33. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 07:00AM EST
  34. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 12:57PM EST
  35. Bluebird Bio Starts First CAR-T Cancer Trial; Juno Gets An Upgrade

    IBD | Feb. 17, 2016 | 14:28PM EST
  36. Bluebird Bio Gains 9% After Co. Begins New Phase 1 Study

    Benzinga | Feb. 17, 2016 | 12:52PM EST
  37. This Mutual Fund Is Powered By Twin Growth Engines

    IBD | Feb. 11, 2016 | 14:20PM EST
  38. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  39. Icahn, Gilead, GE Lead Top Insider Trades Of The Week

    Benzinga | Feb. 9, 2016 | 16:07PM EST
  40. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big Change

    IBD | Feb. 9, 2016 | 12:41PM EST
  41. Barron's: Here Comes $20 Oil

    Benzinga | Feb. 7, 2016 | 11:12AM EST
  42. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD | Feb. 5, 2016 | 09:16AM EST
  43. Maybe Some Good News For A Big Biotech ETF

    Benzinga | Jan. 29, 2016 | 08:39AM EST
  44. Celgene Dips Lower Following Q4 Print

    Benzinga | Jan. 28, 2016 | 09:06AM EST
  45. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  46. Big Earnings Expectations For Big Biotech

    Benzinga | Jan. 24, 2016 | 16:55PM EST
  47. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD | Jan. 15, 2016 | 17:30PM EST
  48. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  49. Celgene Disappoints, Dips

    IBD | Jan. 11, 2016 | 19:29PM EST
  50. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
Trading Center